Abstract:The presence of Lewy body (LB) pathology in addition to Alzheimer disease (AD) pathology is associated with acceleration of AD-related disease progression, according to new research. In a study involving 795 participants with mild cognitive impairment or dementia, individuals with AD + LB + biomarker profiles in their cerebrospinal fluid showed more rapid cognitive decline and greater cortical hypometabolism than those with AD + LB – , AD – LB + or AD – LB – profiles. The findings suggest that the detection of LB pathology could have prognostic value in patients with AD.

Lewy body pathology accelerates AD progression